Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5220303
Max Phase: Preclinical
Molecular Formula: C15H12N2O4S
Molecular Weight: 316.34
Associated Items:
ID: ALA5220303
Max Phase: Preclinical
Molecular Formula: C15H12N2O4S
Molecular Weight: 316.34
Associated Items:
Canonical SMILES: N#Cc1c(NC(=O)c2cc(O)c(O)c(O)c2)sc2c1CCC2
Standard InChI: InChI=1S/C15H12N2O4S/c16-6-9-8-2-1-3-12(8)22-15(9)17-14(21)7-4-10(18)13(20)11(19)5-7/h4-5,18-20H,1-3H2,(H,17,21)
Standard InChI Key: WZXZAQCXHPVIED-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 316.34 | Molecular Weight (Monoisotopic): 316.0518 | AlogP: 2.48 | #Rotatable Bonds: 2 |
Polar Surface Area: 113.58 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 4 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 7.62 | CX Basic pKa: | CX LogP: 3.10 | CX LogD: 2.90 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.64 | Np Likeness Score: -1.55 |
1. Duvauchelle V, Meffre P, Benfodda Z.. (2022) Recent contribution of medicinally active 2-aminothiophenes: A privileged scaffold for drug discovery., 238 [PMID:35696863] [10.1016/j.ejmech.2022.114502] |
2. Al Zahrani NA, El-Shishtawy RM, Asiri AM.. (2020) Recent developments of gallic acid derivatives and their hybrids in medicinal chemistry: A review., 204 [PMID:32731188] [10.1016/j.ejmech.2020.112609] |
Source(1):